Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients

Objectives: This study aims to evaluate influence factors for adjuvant chemotherapy regimen choice on the basis of trastuzumab in older human epidermal growth factor receptor 2 (HER2)-positive breast cancer under multi-disciplinary team (MDT) modality. Materials and Methods: HER2-positive breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yan, Wang, Zheng, Wu, Jiayi, Huang, Ou, He, Jianrong, Zhu, Li, Chen, Weiguo, Li, Yafen, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066021/
https://www.ncbi.nlm.nih.gov/pubmed/32201530
http://dx.doi.org/10.7150/jca.39509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066021/
https://www.ncbi.nlm.nih.gov/pubmed/32201530
http://dx.doi.org/10.7150/jca.39509

Ejemplares similares